C‑Myc inhibitor 10058‑F4 increases the efficacy of dexamethasone on acute lymphoblastic leukaemia cells

Molecular Medicine Reports
Mei LvGuifang Ouyang

Abstract

The long‑term survival rate in paediatric acute lymphoblastic leukaemia (ALL) exceeds 80%; however, the outcome of adult ALL remains to be poor. Glucocorticoids (GCs) are the preferred drugs in the traditional treatment of ALL patients. In the anti‑leukaemia molecular mechanisms of GCs, c‑Myc inhibition serves a critical role. In the present study, a c‑Myc inhibitor that increased the sensitivity to GCs in NALM6 cells of the B‑cell‑ALL cell line and CEM cells of the T‑cell‑ALL cell line was investigated. The data demonstrated that 10058‑F4, a c‑Myc inhibitor, increased the growth inhibition, G0/G1 phase arrest and apoptosis of the NALM6 and CEM cells as induced by dexamethasone (DXM), a type of GC. Additionally, 10058‑F4 reinforced the decreased expressions of c‑Myc, cyclin‑dependent kinase (CDK)‑4 and CDK6 in the NALM6 and CEM cells treated with DXM. These findings indicated that DXM in combination with the c‑Myc inhibitor 10058‑F4 may be a novel, potent therapeutic strategy for the treatment of ALL.

References

Nov 20, 1998·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·N Schreiber-Agus, R A DePinho
Sep 29, 1999·Advances in Experimental Medicine and Biology·P S Gaynon, A L Carrel
Feb 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·H HermekingK W Kinzler
Nov 9, 2000·The Journal of Steroid Biochemistry and Molecular Biology·F ZhouE B Thompson
Jan 23, 2002·Cell Death and Differentiation·C W Distelhorst
Sep 19, 2003·Oncogene·Xiaoying YinEdward V Prochownik
Jul 15, 2004·Blood·Ching-Hon PuiUNKNOWN Total Therapy Study XIIIB at St Jude Children's Research Hospital
Jul 25, 2007·The Journal of Experimental Medicine·Jennifer O'NeilA Thomas Look
Dec 7, 2010·Genes & Cancer·Edward V Prochownik, Peter K Vogt
Apr 20, 2011·Current Drug Targets·Arash S SaffarAbdelilah S Gounni
Nov 18, 2015·American Journal of Hematology·Noelle V Frey, David L Porter
Jun 10, 2016·Nature·Sheela A AbrahamTessa L Holyoake
Feb 6, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yana PikmanKimberly Stegmaier

❮ Previous
Next ❯

Citations

Feb 10, 2021·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Sina M HopffAram Prokop

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.